A Phase 1b Presurgical Window Study to Evaluate Immune Biomarker Modulation in Response to Motolimod and Nivolumab in Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI